6234
  -OEChem-10051719113D

 13 13  0     1  0  0  0  0  0999 V2000
   -1.7919    0.0017    0.0374 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.3808    1.4506   -0.0254 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9168    1.0954   -0.1404 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.4961   -1.4060   -0.2218 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.3914   -0.7225    0.4202 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.9581   -1.1481   -0.1243 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3985    0.7289    0.0544 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4310   -0.8084    1.5114 H   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9317   -1.4043   -1.1908 H   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3785   -1.9939    0.4282 H   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2957    1.9924   -0.4157 H   0  0  0  0  0  0  0  0  0  0  0  0
    1.4407   -2.4049   -0.0276 H   0  0  0  0  0  0  0  0  0  0  0  0
    2.3780   -1.0862    0.1768 H   0  0  0  0  0  0  0  0  0  0  0  0
  1  3  1  0  0  0  0
  1  6  1  0  0  0  0
  2  7  2  0  0  0  0
  3  7  1  0  0  0  0
  3 11  1  0  0  0  0
  4  5  1  0  0  0  0
  4 12  1  0  0  0  0
  4 13  1  0  0  0  0
  5  6  1  0  0  0  0
  5  7  1  0  0  0  0
  5  8  1  0  0  0  0
  6  9  1  0  0  0  0
  6 10  1  0  0  0  0
M  END
> <DATABASE_ID>
DB00260

> <DATABASE_NAME>
drugbank

> <ORIGINAL_SOURCE>
PUBCHEM

> <ORIGINAL_SOURCE_URL>
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/inchikey/DYDCUQKUCUHJBH-UWTATZPHSA-N/SDF?record_type=3d

> <SMILES>
N[C@@H]1CONC1=O

> <INCHI_IDENTIFIER>
InChI=1S/C3H6N2O2/c4-2-1-7-5-3(2)6/h2H,1,4H2,(H,5,6)/t2-/m1/s1

> <INCHI_KEY>
DYDCUQKUCUHJBH-UWTATZPHSA-N

> <FORMULA>
C3H6N2O2

> <MOLECULAR_WEIGHT>
102.0919

> <EXACT_MASS>
102.042927446

> <JCHEM_ACCEPTOR_COUNT>
3

> <JCHEM_AVERAGE_POLARIZABILITY>
8.866828037173109

> <JCHEM_BIOAVAILABILITY>
1

> <JCHEM_DONOR_COUNT>
2

> <JCHEM_FORMAL_CHARGE>
0

> <JCHEM_GHOSE_FILTER>
0

> <JCHEM_IUPAC>
(4R)-4-amino-1,2-oxazolidin-3-one

> <ALOGPS_LOGP>
-2.31

> <JCHEM_LOGP>
-2.421332341545318

> <ALOGPS_LOGS>
0.93

> <JCHEM_MDDR_LIKE_RULE>
0

> <JCHEM_NUMBER_OF_RINGS>
1

> <JCHEM_PHYSIOLOGICAL_CHARGE>
0

> <JCHEM_PKA>
19.998851660051976

> <JCHEM_PKA_STRONGEST_ACIDIC>
4.210086895651751

> <JCHEM_PKA_STRONGEST_BASIC>
8.36186365215875

> <JCHEM_POLAR_SURFACE_AREA>
64.35

> <JCHEM_REFRACTIVITY>
21.848800000000004

> <JCHEM_ROTATABLE_BOND_COUNT>
0

> <JCHEM_RULE_OF_FIVE>
1

> <ALOGPS_SOLUBILITY>
8.77e+02 g/l

> <JCHEM_TRADITIONAL_IUPAC>
cycloserine

> <JCHEM_VEBER_RULE>
0

> <DRUGBANK_ID>
DB00260

> <SECONDARY_ACCESSION_NUMBERS>
APRD00894; DB03123

> <DRUG_GROUPS>
approved

> <GENERIC_NAME>
Cycloserine

> <SYNONYMS>
(+)-4-amino-3-isoxazolidinone; (+)-cycloserine; alpha-Cycloserine; Cicloserina; cyclo-D-Serine; Cyclosérine; Cycloserine; Cycloserinum; D-(+)-cycloserine; D-4-amino-3-isoxazolidinone; D-4-amino-3-isoxazolidone; D-Cycloserine; DCS; Orientomycin; α-Cycloserine

> <PRODUCTS>
Cycloserine; Seromycin; Seromycin Cap 250mg

> <INTERNATIONAL_BRANDS>
Oxamycin; Tisomycin

$$$$
